Agoracom Blog Home

Author Archive

Peak $PKK.ca $PKKFF Successfully Tests Fund Transfer Process from China to Canada $MOS.ca $MOGO.ca CTZ.ca $TRAD.ca

Posted by AGORACOM-JC at 8:25 AM on Wednesday, February 10th, 2021
Peak Fintech Group (@PEAK_Fintech) | Twitter
  • Announced that it has successfully tested the process whereby the its Chinese operating subsidiaries will periodically send funds back to Canada once the Company becomes profitable and deems it appropriate for its subsidiaries to do so.
  • “Today’s announcement has been several years in the making,” commented Peak CEO Johnson Joseph. “We’ve been following our advisors’ advice from day one and were always confident that the process would work as described.

Montreal, Quebec–(February 10, 2021) – Peak Fintech Group Inc. (CSE: PKK) (OTCQX: PKKFF) (“Peak” or the “Company”), an innovative Fintech service provider to the Chinese commercial lending sector, today announced that it has successfully tested the process whereby the its Chinese operating subsidiaries will periodically send funds back to Canada once the Company becomes profitable and deems it appropriate for its subsidiaries to do so.

Long before establishing its operating subsidiaries in China, Peak worked with business consultants, tax experts, legal and financial advisors specialized in helping foreign entities do business in China. Together they helped Peak create and put in place a corporate structure and file the necessary paperwork so that Peak’s subsidiaries could eventually follow a government-established process to send funds to the Company’s Canadian head office. Part of the exercise required a disclosure process with various government departments at the time of registration and creation of each subsidiary, and the continuous maintenance in good standing of prescribed regulations, all of which led to the first successful transfer of funds from Peak’s Asia Synergy Data Solutions subsidiary to the Company.

“Today’s announcement has been several years in the making,” commented Peak CEO Johnson Joseph. “We’ve been following our advisors’ advice from day one and were always confident that the process would work as described. But until recently we weren’t in a position to test it or had real grounds to do so. However, given the path that the Company is currently on and the possibility of repatriating funds from China at some point in 2021, we felt it was important for us to test the process to ensure that it actually works. We have now validated that we have a clear path and process, endorsed and prescribed by the Chinese government authorities, for our subsidiaries to send funds from China to Canada. We’re also very pleased with the amount we were able to transfer and how quickly the transaction was completed.”

Read more: https://agoracom.com/ir/PeakFintechGroup/forums/discussion/topics/755074-peak-successfully-tests-fund-transfer-process-from-china-to-canada/messages/2303017#message

FansUnite $FANS.ca $FUNFF Signs Engagement Letter with Gaming Law Firm to Pursue U.S. Licensing Strategy $SCR.ca $BRAG.ca $TNA.ca $FDM.ca $JJ.ca

Posted by AGORACOM-JC at 8:12 AM on Wednesday, February 10th, 2021

  • Announced that the Company engaged the services of Ifrah Law PLLC, a prominent U.S. gaming law firm to collaborate with OneComply Inc. in assisting FansUnite with their U.S. licensing strategy.
  • Ifrah Law will guide FansUnite in navigating multiple state licenses in 2021, starting with New Jersey

Vancouver, British Columbia–(February 10, 2021) – FansUnite Entertainment Inc. (CSE: FANS) (OTCQB: FUNFF) (“FansUnite” or the “Company”) is pleased to announce that the Company engaged the services of Ifrah Law PLLC (“Ifrah Law”), a prominent U.S. gaming law firm to collaborate with OneComply Inc. (“OneComply”) in assisting FansUnite with their U.S. licensing strategy.

In response to the interest that FansUnite has received from U.S. gambling and casino operators for their sports betting and iGaming solutions, a founding member of Ifrah Law, Jeff Ifrah, will provide counsel to FansUnite on their rapid expansion strategy across the different U.S. jurisdictions beginning with New Jersey.

Jeff is an accomplished lawyer who is nationally ranked by Chambers USA in Gaming & Licensing Law given his reputation for legal excellence as well as his involvement with major prosecutions and lawsuits in the North American iGaming industry. Jeff’s expertise and extensive experience in the U.S. gaming landscape will be integral to FansUnite’s growth in the U.S. online gambling market as the Company seeks to acquire multiple state licenses in 2021, starting with the gaming license of New Jersey. In addition, Jeff has worked with OneComply on numerous occasions and therefore, his contribution will bolster OneComply’s efforts in streamlining the legal process for FansUnite’s entry into the U.S.

“Jeff and his team are a great addition to the global legal team that we have assembled to oversee the delivery of FansUnite’s offerings,” said Scott Burton, CEO of FansUnite. “With a long-standing career as a prominent attorney in gaming law, Jeff will accelerate our expansion into the highly complex U.S. betting and iGaming market.”

Read More: https://agoracom.com/ir/FansUniteEntertainment/forums/discussion/topics/755073-fansunite-signs-engagement-letter-with-gaming-law-firm-to-pursue-u-s-licensing-strategy/messages/2303016#message

Empower Clinics $CBDT.ca $EPWCF Secures Medical Device Establishment Licence (MDEL) Status To Sell KAI Saliva COVID-19 PCR Test Kits In Canada $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 8:05 AM on Wednesday, February 10th, 2021
  • Announced it has secured Medical Device Establishment Licence (“MDEL”) status to sell its KAI Medical COVID-19 Saliva Test kits (“KAI Saliva”).
  • KAI Saliva is FDA EUA approved for use, has CE Mark and the saliva specimen collection device is approved by Health Canada.
  • KAI Saliva provides travellers, both foreign and domestic with a simple, fully compliant method to obtain an RT-PCR test and test result prior to arriving or coming back into to Canada or arriving to other countries that have similar executive travel orders.

VANCOUVER BC / February 10, 2021 / EMPOWER CLINICS INC. (CBDT:CSE) (8EC:Frankfurt) (EPWCF:OTCQB) (“Empower” or the “Company“) an integrated healthcare company serving patients through medical centres, telemedicine platforms, operating a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens, is pleased to announce it has secured Medical Device Establishment Licence (“MDEL”) status to sell its KAI Medical COVID-19 Saliva Test kits (“KAI Saliva”).

KAI Saliva is FDA EUA approved for use, has CE Mark and the saliva specimen collection device is approved by Health Canada. KAI Saliva provides travellers, both foreign and domestic with a simple, fully compliant method to obtain an RT-PCR test and test result prior to arriving or coming back into to Canada or arriving to other countries that have similar executive travel orders.

EMPOWER ACCELERATES ABILITY TO DISTRIBUTE AND SELL MEDICAL DEVICE PRODUCTS IN CANADA THROUGH PARTNERSHIP WITH MEDIPRO CANADA

Empower previously announced the filing of an MDEL application for the purpose of importing, distributing and selling KAI Saliva, which has experienced success upon its launch.

To accelerate the process, Empower partnered with MediPro Canada Inc. (“MediPro”) to utilize their approved MDEL status. MediPro provides healthcare products for governments, large corporations and medical facilities around the world and is led by Hon. Sheila Maureen Copps PC OC.

“We continue to see extensive demand for novel COVID-19 testing products in both private sector and public sector markets throughout North America, Mexico and Caribbean countries.” said Hon. Sheila Copps OC, Partner MediPro Canada. “Leveraging the vast network of MediPro Canada with the integrated healthcare capabilities of Empower Clinics and their novel COVID-19 testing products, makes for an ideal partnership.”

“We all have an urgent requirement for a home-based, self-administered COVID-19 saliva test kit that can help open up the economy and facilitate travel that meets the requirements of the executive travel orders.” said Steven McAuley, Chairman & CEO. “We also must utilize our resources, our reach, our capability, do everything we can to assist, be humanitarians, use our voice, strive to provide improved healthcare, and lead the path of progressive healthcare.”

Read More: https://agoracom.com/ir/EmpowerClinics/forums/discussion/topics/755072-empower-clinics-secures-medical-device-establishment-licence-mdel-status-to-sell-kai-saliva-covid-19-pcr-test-kits-in-canada/messages/2303015#message

ImagineAR $IP.ca $IPNFF Announces Blue United Corporation as its Official Agency for Japan Expansion $DBO.ca $YDX.ca $SEV.ca $NTAR.ca

Posted by AGORACOM-JC at 8:00 AM on Wednesday, February 10th, 2021
http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg
  • Announced a partnership with Blue United Corporation as its official agency to launch the ImagineAR Augmented Reality Platform in Japan
  • Blue United clients include Kashima Antlers, Matsumoto Yamaga , Yanmar, Under Armour, Omiya Ardija and the Pacific League Marketing (holding that represents the commercial interests of 6 teams of the Japanese Baseball League) and Sevilla FC, among others.

VANCOUVER, BC, Feb. 10, 2021 – ImagineAR (CSE: IP) (OTCQB: IPNFF) an Augmented Reality Company that enables sports teams, brands and businesses to instantly create mobile phone AR campaigns, is pleased to announce a partnership with Blue United Corporation as its official agency to launch the ImagineAR Augmented Reality Platform in Japan.  Blue United clients include Kashima Antlers, Matsumoto Yamaga , Yanmar, Under Armour, Omiya Ardija and the Pacific League Marketing (holding that represents the commercial interests of 6 teams of the Japanese Baseball League) and Sevilla FC, among others.

Blue United Corporation is a marketing, PR, and business development agency with offices in New York , Tokyo and Nagano . With a vast experience in International expansion and business development, Blue United Corporation, focuses on elevating brands on a global scale and help them on expanding internationally (business development and expansion, PR/Communications, social media, marketing, etc.), owns and manages the only football professional tournament between club teams that are part of the Pacific Rim Region (Pacific Rim Cup), and is the owner of esports Blue United eFC, current Asian champion of FIFA.

ImagineAR believes Blue United’s experience will significantly accelerate the Company’s presence and sales throughout Japan , a strategic new market for ImagineAR.

Takehiko Nakamura , CEO of Blue United, said; “ImagineAR is the most advanced sports fan engagement Augmented Reality platform in the global market today and we are excited to assist the company to launch its sales and marketing initiatives in Japan . Sports teams can drive new fan engagement and brand activation using ImagineAR and the Japan sports market requires this type of advanced immersive mobile experiential platform to drive new revenue streams.”

Read More: https://agoracom.com/ir/Imaginear/forums/discussion/topics/755071-imaginear-otcqb-ipnff-announces-blue-united-corporation-as-its-official-agency-for-japan-expansion/messages/2303014#message

VIDEO – PyroGenesis $PYR.ca Goes Live For Q&A With Shareholders As Market Cap Surpasses $1 BILLION

Posted by AGORACOM-JC at 6:02 PM on Tuesday, February 9th, 2021

To say that PyroGenesis Canada (PYR:TSX) and its CEO, Peter Pascali, share a mutual love and respect with shareholders unlike anything we have ever seen is not an overstatement.  

This is a group (Company, CEO and Shareholders) that have been through the highs and lows of PyroGenesis over the years TOGETHER.  That bond only got tighter when Pascali took to the PYR Verified Forum on AGORACOM to speak with investors directly and openly with his first ever post on June 21, 2017 followed by more than 20 in-depth videos in which he took his engagement with investors even deeper by answering every single question possible to the best of his ability.  

Knowing this, it should not surprise anybody learning about PyroGenesis for the first time that shareholders have coined the rallying call of “In Peter We Trust”.  

Today PyroGenesis, Pascali and shareholders shared another major milestone together in a live Q&A that coincided with PyroGenesis surpassing a $1 BILLION MARKET CAP.  It was an incredibly special event that could not be made clearer than by many of the questions and comments that referred not just to the Company’s bottom – but to its soul and philosophy.    

I’ve never seen it before.  All I can say is that it is a thrill to be witness to and part of something this deeply special in an industry that rarely looks beyond the next quarter.  

Congratulations to Peter, the Pyro team and this incredible group of shareholders.  

George and the AGORACOM team.  

Watch, listen and enjoy today’s interview with CEO Peter Pascali.

Empower $CBDT.ca $EPWCF Partners with #Rexall $MCK To Launch Integrated Healthcare Centres $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 12:26 PM on Tuesday, February 9th, 2021

Partnership Accelerates Empower’s Strategy To Execute National Healthcare Centre Expansion By Bringing Accessible and Progressive Primary Care and Para-Medical Care to Millions of Canadians

  • Announced effective February 8, 2021 a partnership with Rexall Pharmacy Group to launch the first of multiple integrated healthcare centres within Rexall pharmacies commencing in Ontario, Canada.
  • Empower will be opening primary care, plus para-medical healthcare services in each of the locations, with a target of four (4) to six (6) Medical Doctors (MD) and four (4) to six (6) paramedical practitioners per location.

VANCOUVER, BC / February 9, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) (“Empower” or the “Company“) an integrated healthcare company serving patients through medical centres, telemedicine platforms, operating a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens, is pleased to announce effective February 8, 2021 a partnership with Rexall Pharmacy Group to launch the first of multiple integrated healthcare centres within Rexall pharmacies commencing in Ontario, Canada.

“In our first press release of 2021 announcing the closing of our Canadian Clinics acquisition, I stated Empower had a winning business model with immediate expansion plans throughout Greater Toronto, followed by Ontario and then nationwide with at least 30 clinics in rapid succession. Empower is proud to begin delivering on that promise.” said Steven McAuley, Chairman & CEO. “To say this is the Company’s biggest announcement in its history would not be an over statement. This partnership with Rexall accelerates our nationwide healthcare expansion strategy, I look forward to bringing Six Sigma philosophies and continuous process improvements to our operations to ensure customers and our patients have access to our primary care and para-medical services for years to come. Today marks a major win for Canadian healthcare and the shareholders of Empower Clinics.”

PARTNERSHIP IDENTIFIES INITIAL LOCATIONS IN ONTARIO

Rexall and Empower have identified numerous initial locations throughout Ontario, spanning from Ottawa to London and around the GTA. The size of the locations can range from 1,500 to 4,000 square feet. As each new location is agreed upon, key terms are outlined in a letter of intent and in the lease or sub-lease agreements with the first anticipated agreements February 2021.

HEALTH CARE SERVICES TO BE DELIVERED

Empower will be opening primary care, plus para-medical healthcare services in each of the locations, with a target of four (4) to six (6) Medical Doctors (MD) and four (4) to six (6) paramedical practitioners per location.

Primary care services include:

  • Family physicians
  • Walk-in physicians
  • Tele-medicine and virtual care

Paramedical services include:

  • Chiropractic
  • Physiotherapy
  • Registered Massage Therapy
  • Chiropody
  • Acupuncturists
  • Osteopaths
  • Nutritionists

ADDITIONAL HEALTH CARE SERVICES EXPECTED TO BE ADDED

Given the anticipated expansion and penetration of Empower Clinics into the Canadian market, the Company intends to continue adding valuable specialized medical services to strengthen the quality of healthcare at each location that can include:

  • Dermatology
  • Cardiology

Read More: https://agoracom.com/ir/EmpowerClinics/forums/discussion/topics/754999-empower-partners-with-rexall-r-to-launch-integrated-healthcare-centres/messages/2302856#message

Universal PropTech Inc. $UPI.ca Announces Agreement with LuminUltra Technologies to Provide SARS-CoV-2 #COVID19 Surface Testing #AI #IoT $SNE $MSFT $HON

Posted by AGORACOM-JC at 9:51 AM on Tuesday, February 9th, 2021
  • Entered into an agreement on February 5, 2021 with LuminUltra Technologies Ltd. to deploy their GeneCount Rapid SARS-CoV-2 surface testing solution for UPI’s current and past customers which total over 2,000 facilities including certain aviation assets in Canada today.
  • The Agreement provides UPI the ability to provide testing services employing LuminUltra’s GeneCount® qPCR tests as a service.

Toronto, Ontario–(February 9, 2021) – Universal PropTech Inc. (TSXV: UPI) (“UPI” or the “Company“) is pleased to announce that is has entered into an agreement on February 5, 2021 with LuminUltra Technologies Ltd. (“LuminUltra“) to deploy their GeneCount Rapid SARS-CoV-2 surface testing solution for UPI’s current and past customers which total over 2,000 facilities including certain aviation assets in Canada today. The Agreement provides UPI the ability to provide testing services employing LuminUltra’s GeneCount® qPCR tests as a service.

Chris Hazelton, President and CEO of UPI commented: “We are very excited to bring LuminUltra’s highly reputable SARS-CoV-2 surface testing solution to our customer base in Canada to ensure workplaces are sanitary and safe,” Mr. Hazelton continued: “We had committed strategically to expanding our product mix and investing in key technology to enhance our Trusted Advisor status with our customers. Coupled with our recent announcements, the addition of LuminUltra’s surface testing technology to our suite of services, we are well on our way to meeting that commitment to customers and shareholders.”

UPI’s wholly owned operating subsidiary, VCI Controls, will utilize the LimunUltra GeneCount® qPCR test in order to provide audit support for the efficacy of the various indoor air quality equipment it is installing in customer facilities. In this way, VCI Controls will be able to provide clients with data demonstrating the real world effectiveness of the air sanitization equipment it installs, along with peace of mind for owners and staff alike that Covid-19 is not present in their facilities.

LuminUltra provides testing solutions for clinical diagnostics, surface, and wastewater testing. LuminUltra, through its rapid, accurate and portable qPCR tests help safeguard and protect environments by providing verification of disinfection protocols to confirm the absence of the SARS-CoV-2 virus. This helps identify early warning signs which enables the execution of swift response including contact tracing and human testing.

Fully Portable Manual Testing Using GeneCount® Q-16

To view an enhanced version of this image, please visit:
https://orders.newsfilecorp.com/files/5341/74003_45bb8bd3e4ec081a_002full.jpg

Read More: https://agoracom.com/ir/UniversalPropTech/forums/discussion/topics/754978-universal-proptech-inc-announces-agreement-with-luminultra-technologies-to-provide-sars-cov-2-covid-19-surface-testing/messages/2302823#message

Dr. Jamie Dwyer, Professor of Medicine at Vanderbilt University Joins Draganfly $DFLY.ca $DFLYF Board of Advisors $FLT.ca $UAVS $ALPP

Posted by AGORACOM-JC at 9:43 AM on Tuesday, February 9th, 2021
  • Subject to customary governance approvals, Jamie P. Dwyer M.D. has joined as a member of the Board of Advisors of Draganfly.
  • Dr. Dwyer is a professor of medicine at Vanderbilt University, President of the Collaborative Study Group, and Co-Founder of Innovative Renal Care. Previously he served on the faculty of Mayo Clinic.

Los Angeles, CA, Feb. 09, 2021 — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, today announced, subject to customary governance approvals, Jamie P. Dwyer M.D. has joined as a member of the Board of Advisors of Draganfly.

Dr. Dwyer is a professor of medicine at Vanderbilt University, President of the Collaborative Study Group, and Co-Founder of Innovative Renal Care. Previously he served on the faculty of Mayo Clinic.

Dr. Dwyer has extensive experience working with FDA processes in particular devices and software.

Cameron Chell, CEO of Draganfly, said: “We are excited and truly honored to have Dr. Jamie Dwyer join Draganfly’s outstanding Board of Advisors. Dr. Dwyer brings an incredible understanding and experience with FDA processes and will be key in evolving our Vital Intelligence technology.”

“Draganfly has impressed me with the work they have done with their Smart Vital assessment platform and telehealth app. I am honored to assist a company that has built a solid foundation for innovation within the telehealth sector,” said Dr. Jamie Dwyer.

Dr. Dwyer holds an Sc.B degree in mathematics and Latin from Brown University, and an M.D. with Distinction from Brown University Medical School. He trained in Internal Medicine at Mayo Clinic Florida, where he served as Chief Medical Resident. He trained in Nephrology and Clinical Research at VUMC. After a faculty appointment at Mayo Clinic, he joined the Nephrology Division of VUMC in 2008.

Read More: https://agoracom.com/ir/Draganfly/forums/discussion/topics/754974-dr-jamie-dwyer-professor-of-medicine-at-vanderbilt-university-joins-draganfly-board-of-advisors/messages/2302818#message

$TGS.ca Esports Inc. Announces Launch of TGS Mexico to Support Fast Growing Central American Customer Base $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca

Posted by AGORACOM-JC at 9:08 AM on Tuesday, February 9th, 2021
TGS Esports Announces Intent to Acquire Canadian Esports and Digital Media  Startup, Volcanic Media
  • Announced the launch of TGS Mexico, a new division of the Company focused on servicing its fast growing customer base in Central America
  • TGS, in partnership with Nacion Gamer, has delivered its first two events for the Mexican market. On November 28, 2020 over 12,500 people registered for a Call of Duty Mobile event called Play Like You Mean It, presented by Carl’s Jr.
  • The event was watched live by over 1,100 people and has since been watched over 26,000 times.
  • Video of the event can be viewed here: https://bit.ly/39WcQKZ .

VANCOUVER, BC , Feb. 9, 2021 – TGS Esports Inc. (” TGS ” or the ” Company “) (TSXV: TGS) (FRA: 5RH) is pleased to announce the launch of TGS Mexico, a new division of the Company focused on servicing its fast growing customer base in Central America .

TGS, in partnership with Nacion Gamer, has delivered its first two events for the Mexican market. On November 28, 2020 over 12,500 people registered for a Call of Duty Mobile event called Play Like You Mean It, presented by Carl’s Jr. The event was watched live by over 1,100 people and has since been watched over 26,000 times. Video of the event can be viewed here: https://bit.ly/39WcQKZ .

The two parties teamed up again on January 28, 2021 to present an event celebrating the opening of the 300 th Carl’s Jr. location in Mexico . This event featured eight top Mexican streamers playing Call of Duty Warzone and the broadcast was seen live by over 1,500 people and has been viewed over 135,000 times. Video of this broadcast can be viewed here: https://bit.ly/3aG5tXc .

The launch of TGS Mexico is an important milestone for TGS as it allows the Company to better serve its Central American customers through a dedicated team and platform focused on the esports trends in their market. The success of the Company’s recent events highlights the significant growth opportunities available in the Mexican esports market.

Deeper access to the Mexican market allows for another avenue of revenue and user acquisition for TGS. Having a dedicated team focused on this market allows TGS to embed itself with the local scene and ensure the events being put on serve the market accordingly.

This new entity allows TGS to work in the local currency which is vital to brands and partners looking to engage in esports tournaments and or events.

As TGS continues to work with some of the biggest brands globally to deliver world class esports experiences, the Company is seeing significant growth in the number of users it has access to. Over the last three months TGS has interacted with over 25,000 players participating in over 40 events. With the upcoming official launch of the Pepper platform, TGS will have direct access to players who participate in its events.

“We have been able to put on two successful events in Mexico with a great partner in Nacion Gamer.” said Spiro Khouri , CEO of TGS. “By providing an all-in-one esports solution for large consumer brands, we are providing companies with new and better ways to connect with their audience.”

In 2020, the esports and video games market in Mexico was estimated at 988 million U.S. dollars and it is forecast to increase with a compound annual growth rate of eight percent until 2024, when it will reach 1.34 billion U.S. dollars according to Statista 1 .

The partnership between Nacion Gamer and TGS is expected to continue with more events being announced soon.

Read More: https://agoracom.com/ir/TGSESports/forums/discussion/topics/754971-tgs-esports-inc-announces-launch-of-tgs-mexico-to-support-fast-growing-central-american-customer-base/messages/2302813#message

Avicanna $AVCN.ca $AVCNF Enters Multi-level Strategic Partnership with Al Harrington’s, Harrington Wellness Inc., to Commercialize re+PLAY™ Branded Products in Canada $WEED.ca $CL.ca $HEXO.ca

Posted by AGORACOM-JC at 8:46 AM on Tuesday, February 9th, 2021
http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg
  • Development and licensing of a bespoke and evidence-based athletic line of CBD topical products for the re+PLAY brand in the U.S.
  • Avicanna to lead commercialization in Canada through consumer retail and medical sales channels.

TORONTO, Feb. 09, 2021 — Avicanna Inc. (“ Avicanna ” or the “ Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that the Company has entered into an intellectual property licensing and royalty agreement with Harrington Wellness Inc. (“ Harrington Wellness” ) for the commercialization of a CBD topical product line targeting athletes and active consumers in Canada and the U.S. (the “ re+PLAY Agreement ”). 

Avicanna and Harrington Wellness have worked together extensively on researching, developing and optimizing a bespoke line of CBD-based topicals designed specifically for the athletic and sports community (the “ re+PLAY Products” ). These CBD-based topicals utilize Avicanna’s proprietary deep tissue technology for cannabinoid delivery and have been curated with the support of Harrington Wellness’ deep understanding of the needs of professional athletes. The products are planned to be launched in Q2 2021 in the United States by Harrington Wellness across retail and e-commerce channels and in Canada through medical and adult-use/consumer retail cannabis sales channels by Avicanna. The product formulations are also enrolled in several preclinical studies with leading Canadian medical institutions to assess their efficacy in chronic pain and osteoarthritis. 

Under the re+PLAY Agreement, which has an initial three-year term, Avicanna has licensed the use of certain proprietary product formulations to Harrington Wellness to be used in connection with the manufacture and distribution of the re+PLAY Products in the United States. Additionally, Harrington Wellness has also licensed the use of the re+PLAY brand to Avicanna to be used in connection with the manufacture and distribution of the re+PLAY Products in Canada. The re+PLAY Products will be branded and sold under the re+PLAY brand in both the United States and Canada. Royalties are payable to Avicanna and Harrington Wellness as consideration for each of the licenses. 

“As a former professional athlete myself and avid CBD user, I understand the importance of being in peak physical condition and finding products that help you to recover faster,” says Al Harrington, CEO of Harrington Wellness. “Avicanna has been an incredible partner in developing the re+PLAY formulas and expanding the product line’s availability into Canada.” 

In commenting on the re+PLAY Agreement, Aras Azadian, CEO of Avicanna said, “I am thrilled to finally introduce our relationship with Al Harrington and Harrington Wellness. This partnership was formed on the alignment of the vision to introduce premium and scientifically backed products for athletic and active consumers to the market. Additionally, the distinct expertise of the two companies and collaborative spirit has yielded an advanced and evidence-based line of products that are tailored to promote a healthy active lifestyle for the athlete in all of us.” 

To the knowledge of the Company, it is in compliance with all applicable laws in the jurisdictions in which it operates. 

About Harrington Wellness  

Founded in 2018 by Viola CEO and NBA Vet, Al Harrington, Harrington Wellness produces a wide range of products via in house manufacturing, joint venture projects and white label arrangements with other vetted organizations that stand for the highest quality and reliable medical benefits. These items are sold online via in house and existing marketplace sites, in brick and mortar retail and by health professions directly in their clinics. 

Harrington Wellness’ hero brand, re+PLAY™ is a performance based CBD wellness brand created with the combined knowledge and experience of athletes, doctors, and certified athletic trainers. Our team is dedicated to creating best in class products that deliver the powerful healing properties of the plant to our customers. All products are made using a triple-tested process with hemp grown in the USA, and are free of heavy metals, pesticides, and harmful microbes. 

Read More: https://agoracom.com/ir/Avicanna/forums/discussion/topics/754961-avicanna-enters-multi-level-strategic-partnership-with-al-harrington-s-harrington-wellness-inc-to-commercialize-re-play-branded-products-in-canada/messages/2302800#message